A B S T R A C T Repetitive administration of thyrotropinreleasing hormone (TRH) to human subjects was used to produce small elevations of endogenous serum triiodothyronine (T3) and thyroxine (T4) levels and thereby to determine the effect of these small elevations on the serum thyrotropin (TSH) response to subsequent doses of TRH. Each subject received 13 consecutive doses of 25 ,Ag TRH at 4-h intervals. Serum Ta, T4, and TSH levels were measured before the 1st, 7th, and 13th doses ("basal levels") and for the 4 h after each of these doses.
A B S T R A C T Repetitive administration of thyrotropinreleasing hormone (TRH) to human subjects was used to produce small elevations of endogenous serum triiodothyronine (T3) and thyroxine (T4) levels and thereby to determine the effect of these small elevations on the serum thyrotropin (TSH) response to subsequent doses of TRH. Each subject received 13 consecutive doses of 25 ,Ag TRH at 4-h intervals. Serum Ta, T4, and TSH levels were measured before the 1st, 7th, and 13th doses ("basal levels") and for the 4 h after each of these doses.
In 10 normal subjects, the mean TSH response fell from 14.6 AU/ml after the 1st TRH dose to 6.9 and 3.0 AU/ml after the 7th, and 13th doses. These falls in TSH response were accompanied by rises in the mean basal serum Ts levels from 81 to 115 to 114 ng/100 ml (normal range, 70-150 ng/100 ml) and rises in the mean basal serum T4 from 6.7 to 8.6 to 9.5 ,Ag/lOO ml (normal range, [5] [6] [7] [8] [9] [10] [11] Ag/lOO ml). These data suggest that TRHinduced TSH release is extremely sensitive to inhibition by small elevations, not above the normal ranges, of serum T3 and T4 of endogenous origin. In four patients with primary hypothyroidism, the mean TSH responses were 92, 137, and 92 AU/ml after the 1st, 7th, and 13th TRH doses. The corresponding mean basal serum T3 and T4 levels at the times of these doses were 34, 30, and 32 ng/100 ml and 1.9, 1.9, and 1.7
iAg/lOO ml. These data show that repetitive administration of TRH does not result in progressively lower TSH responses in the absence of corresponding increases in INTRODUCTION Synthetic thyrotropin-releasing hormone (TRH) is a potent stimulus to the release of thyrotropin (TSH) in man (1) (2) (3) . TRH-induced TSH release has already been shown to be impaired dramatically by small elevations of serum triiodothyronine (T3) and thyroxine (T4) levels produced by the administration of exogenous Ts and T4 (4) . The objective of the present study was to determine the effect on TRH-induced TSH release of small elevations of serum T3 and T4 levels of endogenous origin.
A single intravenous dose of TRH has been shown to produce small elevations of serum T3 and T4 levels (5), presumably by stimulating TSH release. Repetitive in- (14) .
h hormone response to arginine infusion and oxycortisol response to oral metyrapone were ie serum testosterone was 311 ng/100 ml (nor-)0 ng/100 ml) in the presence of a serum rmone (LH) of < 5 mIU/ml (normal, < 11 e serum prolactin levels could not be assayed ise of the prior administration of commercial of vasopressin for diabetes insipidus (14).
3-yr old woman was diagnosed presumptively *pothyroidism due to idiopathic pituitary in-TRH. This diagnosis was based on the find-I) of low serum T3, T4, and f ree T4 levels, roidal response to exogenous TSH, a low-TSH before TRH, and a subnormal serum ;e to the 400 ug test dose of synthetic TRH. ic appearance of the sella turcica was normal. mrone secretion was otherwise subnormal: the h hormone response to arginine infusion and oxycortisol response to metyrapone were subher serum LH, at age 53, 22 yr after vaginal was 5 mIU/ml. The serum prolactin response TRH was at the lower limit of normal comie response of euthyroid, normal subjects and d with the response of subjects with primary m (11) . This prolactin response to TRH is th the assumption that the anatomic site of hormonal abnormalities is the pituitary gland, e hypothalamus. al dcsign. Each subject and patient received e 25-,ug doses of synthetic TRH at 4-h inter-'H (Abbott Laboratories, North Chicago, Ill.) was given intravenously as a bolus injection via an indwelling scalp-vein needle, which was flushed with saline and then filled with aqueous heparin after each TRH injection. Blood samples were drawn from the opposite arm before and for 4 h after the 1st, 7th, and 13th TRH doses. On each of these occasions blood samples were obtained at 0, 5, 10, 15, 20, 30, 45, 60, 90, 120, 180, and 240 min.
Analyses. Serum TSH (10), prolactin (14) (courtesy of Doctors L. S. Jacobs and W. H. Daughaday), and Ta (15) were measured by radioimmunoassays. Serum T4 (16) was measured by competitive protein binding. All samples for the determination of either TSH, T8, or T4 from any one subject were analyzed inthe same assay run. All statistical analyses were made by use of the paired t test (17) . When an individual serum Ts level was below the lower limit of detection of the T3 assay, 30 ng/100 ml, as occurred in the patients with primary hypothyroidism, the value was assumed to be 30 ng/100 ml for determining the mean serum Ts levels in these patients. In reporting and discussing the results, the term "basal" is used to refer to zero time of any specified TRH dose. The term "maximum ATSH" is used to refer to the maximum increment in TSH above the basal level after any specified TRH dose. co RESULTS Normal subjects. The serum TSH responses of the 10 normal subjects to the intravenous injection of 13 consecutive 25-jsg doses of TRH at 4-h intervals are shown in Fig. 1 . After the first dose of TRH the mean serum TSH rose from a basal level of 4.4±0.6 /AU/ml (SEM) to a maximum of 18.5±2.3 izU/ml at 20 min. After the seventh dose of TRH the mean serum TSH rose from a basal level of 4.1±0.7 ,uU/ml to a maximum of 10.8±2.0 ,AU/ml. After the 13th dose of TRH the mean serum TSH rose from a basal level of 3.1±0.5 /AU/ml to a maximum of 5.8±1.1 uU/ml. The fall in mean basal TSH levels from the lst to the 13th test, 4.4-3.1 izU/ml, although small, was significant (P < 0.02). The statistical significance of the fall in the TSH responses to TRH is described below.
The serum Ta and T4 responses to the 1st, 7th, and 13th TRH doses are shown in Table II . After the first TRH dose the mean serum Ts level rose to a peak 2 h after the dose. The peak level was 31% greater (P < 0.001) than the base-line level. The mean serum T. level after the first TRH dose also reached a peak 2 h after the dose. The peak level was only 10% greater than the serum T3 had risen to 115±5 ng/100 ml (P < 0.001) and the mean basal serum T4 had risen to 8.6±0.3 Ag/ 100 ml (P < 0.01), the mean maximum ATSH declined to 6.9±1.4 /U/ml (P < 0.001). At the time of the 13th dose, when the mean basal serum T3 had remained virtually unchange(l at 114±5 ng/100 ml and the mean basal serum T4 had increased slightly to 9.5±0.3 Ag/100 ml (P < 0.05), the mean maximum ATSH declined further to 3.0±0.7 AU/ml (P < 0.005).
Primtary hypothyroidismji. The (Table III) .
Correlation of the mean basal serum T3 and T4 levels at the time of each dose with the mean maximum ATSH 200 100 13TH FIGURE 2 Correlation of the changes in maximum ATSH with the changes in basal serum T3 and(l T4 levels in response to repetitive doses of TRH in 10 normal subjects. "Basal" refers to the level just before a TRH dose, and "maximum A" refers to the maximum inicrement above the basal level during the 4 h after a TRH dose. Vertical lines represent +SEMI.
base-line level, but this increase was statistically significant (P < 0.01). After the 7th and 13th doses, however, the mean serum T3 and T4 levels, although starting from higher basal levels than at the time of the 1st dose, failed to rise above the basal levels. The 240-min serum T3 and T4 levels were, in fact, less (P < 0.05) than the corresponding basal values at the times of both the 7th and 13th doses.
Correlation of the mean basal serum Ta and T4 levels at the time of each dose with the maximum ATSH after that dose is shown in Fig. 2 . At the time of the first dose, when the mean basal serum T3 was 81±3 ng/100 ml and the mean basal serum T4 was 6.7+0.3 Ag/lOO ml, the mean maximum ATSH was 14.6±2.2 uU/ml. The procedure was the same as described for normal subjects in Fig. 1 Mean serum Ts and T4 levels after repetitive doses of TRH in the four patients with primary hypothyroidism whose TSH responses are shown in Fig. 3 . No statistically significant changes occurred.
after that dose is shown in Fig. 4 . In contrast to the normal subjects, these patients with primary hypothyroidism had neither increases in the mean basal serum T3 and T4 levels nor a fall in the mean maximum -ATSH response to successive doses of TRH. The mean basal serum T3 levels were 34±2, 30+1, and 32±1 ng/100 ml, and the mean basal serum T4 levels were 1.9+0.4, 1.9+ 0.5, and 1.7±0.4 Ag/100 ml at the times of the 1st, 7th, and 13th doses. The mean maximum ATSH responses were 92±29, 137±52, and 92±24 AU/ml, respectively. Patients with hypothyrotropic hypothyroidism. The serum TSH responses of the three patients with hypothyrotropic hypothyroidism, L. C., K. C., and M. J., to 13 consecutive 25-iAg doses of TRH at 4-h intervals are shown in Fig. 5 . L. C., who had presumed TRH deficiency, had a maximum TSH response after the first TRH dose of 27.0 AU/ml, at the upper limit of the normal range. Her maximum TSH responses fell progressively to 13.8 and then 6.5 /AU/ml after the 7th and 13th TRH doses. These responses were also within the Effects of Repetitive TRH on Serum Ts, T4, and TSH ranges of the normal subjects. K. C., w-ho also had presumed TRH deficiency, had maximum TSH levels of 13.0, 10.3, and 6.4 AU/ml in response to the 1st, 7th, and 13th TRH doses. In contrast, M. J., who had presumed pituitary insensitivity to TRH, had a maximum TSH response to the first TRH dose of 7.5 AU/ml, at the lower limit of the normal range. Not only w-as her peak TSH response low inl magnitude, but it was also delayed, occurring 45 min after the TRH. Her maximum TSH levels fell to 4.7 MU/mnl after both the 7th anid 13th TRH doses.
Correlation of the basal serumil T3 anid T4 levels at the time of each TRH dose in patients L. C., K. C., and M. J. with the maximum ATSH values after the dose is shown in Fig. 6 . Like the normal subjects, these patients showed decreases in maximum ATSH as the basal T3 and T4 levels rose. They differed from the normal subjects, however, in other respects. L. C.'s basal serum T3 and T4 levels were initially subnormal: the T3 wX-as 50 ng/100 ml, and the serum T4 was 3.0 Lg/100 ml. At the time of the 13th TRH dose L. C.'s basal serum T3 level had risen to 90 ng-'100 mln and her basal serum T4 level had risen to 6.5 g/100 ml, both withini the initial basal ranges of the 10 inormal subjects, as wrell as within the ranges of a larger normal population, 70-150 ng/100 ml for T3 and 5-11 Mg/G100 ml for T4 (6, 7) . She had, therefore, been made "euithyroid" by 13 consecutive 4-h 25-'g TRH doses. Patient K. C. w%as also made chemically euthyroid by repetitive TRH administration. His basal serum T3 levels rose from 58 to 92 to 120 ng/100 ml. and his basal serum T4 levels rose from 3.8 to 6.6 to 9.3 Iug/lOO ml. Simultaneously his maximum ATSH responses fell from 10.2 to 6.5 to 3.2 yU/mI. M. J.'s iniitial basal T3 and T4 levels were also subnormal, 37 ng/100 ml aind 2.9 mg/100 mfl. At the time of the 13th (lose the basal T3 and T4 levels had risen, to 46 ng/100 ml and 3.4 mg/IlO ml, but not to within the initial basal ranges of the normal subjects or to within the ranges of normal of the general population. Even these small rises in serum T3 and T4 levels, however, were associated with a fall in M\. J.'s maximum ATSH from a lowv level, 4.7 U/nml, in response to the 1st TRH dose, to an even lower one, 1.3 muU/mIl, in response to both the 7th and 13th doses.
DISCUSSION
The data presented here demonstrate the extreme sensitivity of TRH-stimulated TSH release to inhibition by small elevations of serum T3 and T4 of endogenous origin. Repetitive administration of 25-Ag doses of TRH every 4 h to normal subjects produced a steady fall in the TSH response, the maximum ATSH responses after the 7th and 13th doses being 47 and 21% of that after the lst dose. This striking fall in the TSH response to TRH was associated with rises in serum T3 and T4 levels but not above the normal ranges of either T3 or T4. Both the small rises in the serum T3 and T4 levels and observed in the present study were quite similar in magnitude to those observed in a previous study in Nvhich these changes were produced by the administration of small quantities of exogenous T3 and T4. These similarities to the previous study, in which TRH was administered no more frequently than once every 3-4 wk (4), are evidence that the inhibition of TRH-induced TSH release observed in the present study was due to the small rises in serum Ts and T4 levels. Further, and more conclusive, evidence that the marked inhibition of TSH response in the normal subjects was due to the small rises in serum T3 and T4 levels is the data presented here from patients with primary hypothyroidism. These patients, who had no increases in serum Ta and T4 levels in response to repetitive TRH administration, had no decrease in TSH responses. This finding demonstrates that repetitive TRH administration, in the schedule used here, does not result in progressively lower TSH repsonses in the absence of rises in serum T3 and T4 levels. This finding, therefore, appears to exclude the possibility that the progressive fall in serum TSH response to repetitive TRH administration observed in the normal subjects was due to progressive depletion of pituitary TSH.
One implication of the data presented here is thatt production of elevations of serum T3 and T4 distinctly above the normal ranges due to supranormal secretion of endogenous TRH should be unlikely unless the endogenous TRH secretion were several orders of magnitude greater than normal.
The two patients with presumed hypothalamic hypothyroidism, L. C. and K. C., also demonstrated inhibition of TSH release by repetitive administration of TRH but only as the serum Ts and T4 levels rose into the normal ranges. TRH deficiency appears, therefore, to have been confirmed by producing chemical euthyroidism by replacement of the presumedly missing hormone. Several other patients, however, have been described who, like L. C., and K. C., had low serum thyroid hormone and low-normal basal TSH levels and normal TSH responses to a single dose of TRH (18) (19) (20) (21) (22) . The marked fall in the initially subnormal TSH response to TRH in M. J., the patient with presumed pituitary insensitivity to TRH, was accompanied by rises in serum T3 and T4, but rises so small that the final levels were still subnormal. That rises in serum T3 and T4 levels not sufficient to reach the normal ranges could cause such an inhibition of the TSH response to TRH demonstrates that the extreme sensitivity of TRH-induced TSH release to inhibition by small rises in endogenously secreted T3 and T4 was preserved in MI. J., even though the sensitivity to TRH was diminished. Since stimulation of TSH release by TRH occurs by a different mechanism than inhibition of TSH release by thyroid hormones (23, 24) , an abnormality of responsiveness to TRH without an abnormality of inhibitionl by thyroid hormones is not surprising.
